- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Graphene 3D Lab Receives Approval for Next Task of R&D-Royalty Agreement with Fortune 500 Manufacturer
Graphene 3D Lab Inc. (TSXV:GGG,OTCQB:GPHBF) announced that it has been approved to move forward with the next task of its research, development and royalty agreement with a Fortune 500 listed manufacturer.
Graphene 3D Lab Inc. (TSXV:GGG,OTCQB:GPHBF) announced that it has been approved to move forward with the next task of its research, development and royalty agreement with a Fortune 500 listed manufacturer.
As quoted in the press release:
The Agreement encompasses the development of multi-phased deliverables over the course of approximately a year. For competitive reasons and pursuant to confidentially clauses contained with the Agreement, neither specific research objectives nor the identity of the Fortune 500 manufacturer can be publically disclosed. Upon successful completion of the research phase, and subject to approval by the U.S. Food & Drug Administration, the developed materials will become a part of a consumer retail product.
Graphene 3D Lab Co-Chief Executive Officer, Elena Polyakova, stated:
We are fortunate to have a world leading R&D team in the graphene and nanomaterial field. Meeting or exceeding all of a client’s performance criteria is another example of how we are ideally suited to work with existing manufacturers to assist them with incorporating graphene into their products.
Connect with Graphene 3D Lab Inc. (TSXV:GGG,OTCQB:GPHBF) to receive an Investor Presentation.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.